Prenetics Global Limited (PRE): Next-Year EPS Estimate 88.94%
As of 2026-06-11, Prenetics Global Limited (PRE) has a next-year EPS growth estimate of 88.94%.
On 2026-06-11, analyst consensus for PRE's next-year EPS growth shifted from 85.01% to 88.94% — a positive change of 3.93 percentage points. Current-year growth is projected at 15.90%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 88.94%
- EPS growth this year
- 15.90%
- EPS next quarter (est)
- -$0.74
- Last price
- $20.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 88.94% | 15.90% | -$0.74 | $20.69 |
| 2026-06-10 | 85.01% | 11.54% | -$0.84 | $19.25 |
| 2026-06-09 | 85.01% | 11.54% | -$0.84 | $20.93 |
| 2026-06-08 | 85.01% | 11.54% | -$0.84 | $20.00 |
| 2026-06-07 | 85.01% | 11.54% | -$0.84 | $19.86 |
| 2026-06-04 | 85.01% | 11.54% | -$0.84 | $20.79 |
| 2026-06-03 | 85.01% | 11.54% | -$0.84 | $20.83 |
| 2026-06-02 | 85.01% | 11.54% | -$0.84 | $20.97 |
| 2026-06-01 | 85.01% | 11.54% | -$0.84 | $20.39 |
| 2026-05-31 | 85.01% | 11.54% | -$0.84 | $21.10 |
| 2026-05-28 | 85.01% | 11.54% | -$0.84 | $20.18 |
| 2026-05-27 | 85.01% | 11.54% | -$0.84 | $17.26 |
| 2026-05-26 | 85.01% | 11.54% | -$0.84 | $17.81 |
| 2026-05-25 | 85.01% | 11.54% | -$0.84 | $16.77 |
| 2026-05-24 | 85.01% | 11.54% | -$0.84 | $16.77 |
| 2026-05-21 | 85.01% | 11.54% | -$0.84 | $15.92 |
| 2026-05-20 | 85.01% | 11.54% | -$0.84 | $15.47 |
| 2026-05-19 | 85.01% | 11.54% | -$0.84 | $14.61 |
| 2026-05-18 | 85.01% | 11.54% | -$0.84 | $14.54 |
| 2026-05-17 | 85.01% | 11.54% | -$0.84 | $15.61 |
| 2026-05-14 | 92.45% | 16.95% | -$0.82 | $17.59 |
| 2026-05-13 | 92.45% | 16.95% | -$0.82 | $17.76 |
| 2026-05-12 | 92.45% | 16.95% | -$0.82 | $17.99 |
| 2026-05-11 | 92.45% | 16.95% | -$0.82 | $17.55 |
| 2026-05-10 | 92.45% | 16.95% | -$0.82 | $16.16 |
| 2026-05-07 | 92.45% | 16.95% | -$0.82 | $15.87 |
| 2026-05-06 | 92.45% | 16.95% | -$0.82 | $15.90 |
| 2026-05-05 | 92.45% | 16.95% | -$0.82 | $16.73 |
| 2026-05-04 | 92.45% | 16.95% | -$0.82 | $16.50 |
| 2026-05-03 | 92.45% | 16.95% | -$0.82 | $17.02 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Prenetics Global Limited's next-year EPS growth estimate?▾
As of 2026-06-11, Prenetics Global Limited (PRE) has a next-year EPS growth estimate of 88.94%, based on analyst consensus.
When was the latest EPS estimate revision for PRE?▾
The most recent revision occurred on 2026-06-11, when analysts adjusted the next-year EPS growth estimate from 85.01% to 88.94%.
What sector and industry does Prenetics Global Limited belong to?▾
Prenetics Global Limited operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PRE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Prenetics Global Limited (PRE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports